Kentucky Retirement Systems Insurance Trust Fund Raises Stake in DaVita Inc. (NYSE:DVA)

Kentucky Retirement Systems Insurance Trust Fund lifted its stake in DaVita Inc. (NYSE:DVAFree Report) by 357.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,252 shares of the company’s stock after buying an additional 4,886 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in DaVita were worth $935,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. MML Investors Services LLC lifted its holdings in shares of DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after buying an additional 68 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of DaVita by 8.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after buying an additional 68 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of DaVita by 1.5% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock worth $776,000 after buying an additional 70 shares in the last quarter. Impact Partnership Wealth LLC lifted its holdings in shares of DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares in the last quarter. Finally, Contravisory Investment Management Inc. increased its position in DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after purchasing an additional 73 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Down 1.6 %

DVA stock opened at $154.98 on Wednesday. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $119.42 and a twelve month high of $179.60. The stock has a market capitalization of $12.40 billion, a price-to-earnings ratio of 14.43, a price-to-earnings-growth ratio of 0.79 and a beta of 0.94. The firm’s fifty day simple moving average is $161.41 and its two-hundred day simple moving average is $157.91.

DaVita (NYSE:DVAGet Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, analysts anticipate that DaVita Inc. will post 10.93 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Barclays boosted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $162.80.

Get Our Latest Stock Analysis on DaVita

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.